Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2001

View Archived Issues

Canadian trials of ISAtx-247 commence in psoriasis patients

Inhalable tobramycin for lung infections shown to be superior to nebulization

Patient enrollment complete for pivotal palonosetron trial

FDA approves Entocort EC for treatment of Crohn's disease

First monthly vaginal contraceptive ring granted marketing approval in the U.S.

Biovail files NDA for FlashDose version of fluoxetine

Schering-Plough launches combination therapy to treat hepatitis C

Chemopreventive effects of retinoid compound NIK-333

Apoptotic effect of TAS-106 investigated in human leukemia cells

Two doses of SR-57746A evaluated in open trial in Japanese ALS patients

Fampridine-SR well tolerated in patients with chronic SCI

Nonhormonal strategies for menopausal symptoms a hot topic

Chondroprotective anthraquinones with potential in osteoarthritis

Lead IGFBP-3 ligand inhibitor identified at Neurocrine Biosciences

French investigators present new 8-alkylamino-1,4-benzoxazine neuroprotectants

Forty-eight-week results support efficacy of adefovir dipivoxil in HBV/HIV-coinfected subjects

Inhibitors of IKK-2 claimed by AstraZeneca for treating inflammatory diseases

Development of Latranal discontinued by Praecis

New carboxamides with TNF- and/or PDE4-inhibitory activity under study at Darwin Discovery

Aventis presents new echinocandin derivatives with good antifungal activity

New delta opioid receptor agonists and their use described by Japanese lab

Antimicrobial polypeptides from Fujisawa particularly useful against fungi

Inhibitors of NEP, ECE and/or ACE described in recent patent

New compounds designed at Welsh university inhibit retinoic acid metabolism

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...